In-Vitro Diagnostics (IVD) Market

Market Insights

The global in-vitro diagnostics (IVD) market has considerably evolved over the past decade with innovative diagnosis options. Significant factors contributing to the growth of the in-vitro diagnostics market include the growing incidence of chronic diseases, the aging population, and the growing demand for point-of-care testing. In addition, advancements in genomics and proteomics, the introduction of condition-specific markers, and the development of healthcare infrastructure in emerging economies create prospects for the market.

This report studies the global in-vitro diagnostics market on the basis of four major segmentations: products, techniques, test locations, and geography. Reagents, instruments, software, and services make the IVD market by products. Clinical chemistry, immunochemistry/immunoassays, hematology, coagulation and hemostasis, microbiology, molecular diagnostics (MDX), and others are the IVD techniques studied in the report. IVD is practiced across point-of-care testing, central lab testing, and OTC/self-testing based on test locations. Each of the mentioned segments is analyzed for its market size, forecast, and major trends observed in each category. The market size and forecast are provided for 2014-2022 with the individual compounded annual growth rates (CAGR %) for 2016-2022 while considering 2015 as the base year.

Based on geographical distribution, the global in-vitro diagnostics market is studied for North America, Europe, Asia-Pacific, Middle East, Africa, and Latin America regional markets. Analysis of key country-level markets for major regional markets is also provided in this study. Market size and forecast for each region and the country-level market are provided in this report for 2014-2022, along with their respective CAGRs during 2016-2022, considering 2015 as the base year.

This distribution is elucidated as follows:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • Italy
  • U.K.
  • Russia
  • Rest of Europe
• Asia-Pacific
  • India
  • China
  • Japan
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East and Africa
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

Along with the quantitative data, qualitative information sets such as market dynamics and executive summary for the global in-vitro diagnostics market are included in the report. Fractal map analysis and attractive investment proposition tools are also included in the report or competition assessment. This study concludes with the company profiles section, which includes major information about the key companies engaged in developing, manufacturing, and selling IVD technologies.

Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology

Chapter 2 Executive Summary
2.1 In-vitro Diagnostics Market Share, by Products, 2015 & 2022 (Value %)
2.2 In-vitro Diagnostics Market, by Techniques, 2015 (USD Mn)
2.3 In-vitro Diagnostics Market, by Test Locations, 2015 (USD Mn)
2.4 In-vitro Diagnostics Market Share, by Geography, 2015 (Value %)

Chapter 3 In-vitro Diagnostics Market: Market Dynamics and Outlook
3.1 Introduction, Facts and Figures
3.2 Drivers
3.3 Challenges
3.4 Future Prospects
3.5 Attractive Investment Proposition
3.1 Competitive Analysis: Fractal Map Investigation, by Key Market Players

Chapter 4 Global In-vitro Diagnostics Market Analysis, by Products
4.1 Preface
4.2 Reagents
4.3 Instruments
4.4 Software and Services

Chapter 5 Global In-vitro Diagnostics Market Analysis, by Techniques
5.1 Preface
5.2 Clinical Chemistry
5.3 Immunochemistry/Immunoassays
5.4 Hematology
5.5 Coagulation and Hemostasis
5.6 Microbiology
5.7 Molecular Diagnostics (MDX)
5.8 Others

Chapter 6 Global In-vitro Diagnostics Market Analysis, by Test Locations
6.1 Preface
6.2 Point-of-Care Testing
6.3 Central Lab Testing
6.4 OTC/Self Testing

Chapter 7 Global In-vitro Diagnostics Market, by Geography
7.1 Preface
7.2 North America
7.3 Europe
7.4 Asia-Pacific
7.5 Middle East and Africa (MEA)
7.6 Latin America

Chapter 8 Company Profiles
8.1 Abbott Laboratories, Inc.
8.1.1 Business Description
8.1.2 Financial Health and Budget Allocation
8.1.3 Product Positions/Portfolio
8.1.4 News Coverage
8.2 Bayer AG.
8.2.1 Business Description
8.2.2 Financial Health and Budget Allocation
8.2.3 Product Positions/Portfolio
8.2.4 News Coverage
8.3 Becton, Dickson and Company
8.3.1 Business Description
8.3.2 Financial Health and Budget Allocation
8.3.3 Product Positions/Portfolio
8.3.4 News Coverage
8.4 bioMérieux
8.4.1 Business Description
8.4.2 Financial Health and Budget Allocation
8.4.3 Product Positions/Portfolio
8.4.4 News Coverage
8.5 Bio-Rad Laboratories, Inc.
8.5.1 Business Description
8.5.2 Financial Health and Budget Allocation
8.5.3 Product Positions/Portfolio
8.5.4 News Coverage
8.6 Danaher Corporation
8.6.1 Business Description
8.6.2 Financial Health and Budget Allocation
8.6.3 Product Positions/Portfolio
8.6.4 News Coverage
8.7 Johnson & Johnson Pvt Ltd.
8.7.1 Business Description
8.7.2 Financial Health and Budget Allocation
8.7.3 Product Positions/Portfolio
8.7.4 News Coverage
8.8 Roche Diagnostics
8.8.1 Business Description
8.8.2 Financial Health and Budget Allocation
8.8.3 Product Positions/Portfolio
8.8.4 News Coverage
8.9 Siemens AG
8.9.1 Business Description
8.9.2 Financial Health and Budget Allocation
8.9.3 Product Positions/Portfolio
8.9.4 News Coverage
8.10 Sysmex Corporation
8.10.1 Business Description
8.10.2 Financial Health and Budget Allocation
8.10.3 Product Positions/Portfolio
8.10.4 News Coverage
8.11 Others
8.11.1 Business Description
8.11.2 Financial Health and Budget Allocation
8.11.3 Product Positions/Portfolio
8.11.4 News Coverage

List Of Figure

FIG. 1 In-vitro Diagnostics: Market Segmentation
FIG. 2 In-vitro Diagnostics Market Share, by Products, 2015 & 2022 (Value %)
FIG. 3 In-vitro Diagnostics Market, by Techniques, 2015 (USD Mn)
FIG. 4 In-vitro Diagnostics Market, by Test Locations, 2015 (USD Mn)
FIG. 5 In-vitro Diagnostics Market Share, by Geography, 2015 (Value %)
FIG. 6 Attractive Investment Proposition, In-vitro Diagnostics Market, 2015
FIG. 7 Competitive Analysis: Fractal Map Investigation, by Key Market Players
FIG. 8 Global IVD Reagents Market, 2014 – 2022 (USD Mn)
FIG. 9 Global IVD instruments Market, 2014 – 2022 (USD Mn)
FIG. 10 Global IVD Software and Services Market, 2014 – 2022 (USD Mn)
FIG. 11 Global Clinical Chemistry IVD Market, 2014 – 2022 (USD Mn)
FIG. 12 Global Immunochemistry/Immunoassays IVD Market, 2014 – 2022 (USD Mn)
FIG. 13 Global Hematology IVD Market, 2014 – 2022 (USD Mn)
FIG. 14 Global Coagulation and Hemostasis IVD Market, 2014 – 2022 (USD Mn)
FIG. 15 Global Microbiology IVD Market, 2014 – 2022 (USD Mn)
FIG. 16 Global Molecular Diagnostics (MDX) IVD Market, 2014 – 2022 (USD Mn)
FIG. 17 Global Other IVD Techniques IVD Market, 2014 – 2022 (USD Mn)
FIG. 18 Global IVD in Point-of-Care Testing Market, 2014 – 2022 (USD Mn)
FIG. 19 Global IVD in Central Lab Testing Market, 2014 – 2022 (USD Mn)
FIG. 20 Global IVD in OTC/Self Testing Market, 2014 – 2022 (USD Mn)
FIG. 21 U.S. In-vitro Diagnostics Market, 2014 – 2022 (USD Mn)
FIG. 22 Canada In-vitro Diagnostics Market, 2014 – 2022 (USD Mn)
FIG. 23 U.K. In-vitro Diagnostics Market, 2014 – 2022 (USD Mn)
FIG. 24 Germany In-vitro Diagnostics Market, 2014 – 2022 (USD Mn)
FIG. 25 Rest of Europe In-vitro Diagnostics Market, 2014 – 2022 (USD Mn)
FIG. 26 Japan In-vitro Diagnostics Market, 2014 – 2022 (USD Mn)
FIG. 27 China In-vitro Diagnostics Market, 2014 – 2022 (USD Mn)
FIG. 28 Rest of Asia-Pacific In-vitro Diagnostics Market, 2014 – 2022 (USD Mn)
FIG. 29 Middle East and Africa In-vitro Diagnostics Market, 2014 – 2022 (USD Mn)
FIG. 30 Latin America In-vitro Diagnostics Market, 2014 – 2022 (USD Mn)

List Of Table

TABLE 1 Global In-vitro Diagnostics Market, by Products, 2014 – 2022 (USD Mn)
TABLE 2 Global In-vitro Diagnostics Market, by Techniques, 2014 – 2022 (USD Mn)
TABLE 3 Global In-vitro Diagnostics Market, by Test Locations, 2014 – 2022 (USD Mn)
TABLE 4 Global In-vitro Diagnostics Market, by Geography, 2014 – 2022 (USD Mn)
TABLE 5 North America In-vitro Diagnostics Market, by Country, 2014 – 2022 (USD Mn)
TABLE 6 Europe In-vitro Diagnostics Market, by Country, 2014 – 2022 (USD Mn)
TABLE 7 Asia-Pacific In-vitro Diagnostics Market, by Country, 2014 – 2022 (USD Mn)